Trial site
The First Affiliated Hospital of Baotou Medical College
- 13running trials
- 10closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease4 trials
- Lupus (SLE)4 trials
- Stroke3 trials
- Asthma2 trials
- IgA nephropathy2 trials
- Heart failure1 trial
- Migraine1 trial
- Psoriasis1 trial
- Vitiligo1 trial
- Phase
- Phase 39 trials
- Phase 26 trials
- Phase 2/33 trials
- Phase 12 trials
- Phase 1/21 trial
- Status
- Completed10 trials
- Recruiting6 trials
- Active, not recruiting4 trials
- Not yet recruiting3 trials
- Lead sponsor
- Pfizer3 trials
- Bayer2 trials
- EMD Serono Research & Development Institute, Inc.2 trials
- Beijing Tiantan Hospital1 trial
- BeOne Medicines1 trial
- and 14 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Recruiting
Not yet recruiting
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Active, not recruiting
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- IgA nephropathy2 recruiting
- Asthma1 recruiting
- Heart failure1 recruiting
- Lupus (SLE)1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001
Completed
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
Completed
Completed
Completed
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)
Completed
Completed
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
Site data: ClinicalTrials.govUpdated 19 Nov 2026